AMEH:NSD-Apollo Medical Holdings Inc (USD)

COMMON STOCK | Medical Care Facilities | NSD

Last Closing Price

USD 29.70

Change

+0.50 (+1.71)%

Market Cap

USD 1.33B

Volume

0.23M

Avg Analyst Target

USD 57.00 (+91.92%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


AMEH Stock Forecast & Price:
Based on the Apollo Medical Holdings Inc stock forecasts from 2 analysts, the average analyst target price for Apollo Medical Holdings Inc is USD 57.00 over the next 12 months. Apollo Medical Holdings Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Apollo Medical Holdings Inc is Slightly Bullish , which is based on 5 positive signals and 3 negative signals. At the last closing, Apollo Medical Holdings Inc’s stock price was USD 29.70. Apollo Medical Holdings Inc’s stock price has changed by +4.84% over the past week, -20.10% over the past month and -63.31% over the last year.

About Apollo Medical Holdings Inc (AMEH:NSD)

Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-12-08 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ACHC Acadia Healthcare Company Inc

+1.38 (+1.68%)

USD7.58B 27.96 16.67
OPCH Option Care Health Inc

+0.45 (+1.52%)

USD5.50B 29.34 21.16
LHCG LHC Group

-0.10 (-0.06%)

USD5.12B 80.44 30.52
ENSG The Ensign Group Inc

+1.51 (+1.64%)

USD5.11B 24.56 18.43
SGRY Surgery Partners Inc

-0.03 (-0.11%)

USD3.00B 63.00 14.11
AMED Amedisys Inc

+0.72 (+0.83%)

USD2.81B 23.40 13.59
PRSC The Providence Service Corpora..

N/A

USD2.21B 74.23 15.08
LFST Lifestance Health Group Inc

-0.06 (-1.05%)

USD2.12B N/A -10.62
ADUS Addus HomeCare Corporation

-0.17 (-0.16%)

USD1.71B 38.79 23.35
MODV ModivCare Inc

+0.20 (+0.22%)

USD1.22B N/A 12.32

ETFs Containing AMEH

Symbol Name Weight Mer Price(Change) Market Cap
IWC iShares Micro-Cap ETF 0.00 % 0.60 %

+1.34 (+1.23%)

USD0.92B
PTH Invesco DWA Healthcare Mo.. 0.00 % 0.60 %

+1.46 (+1.20%)

USD0.24B
XSMO Invesco S&P SmallCap Mome.. 0.00 % 0.37 %

-0.11 (-0.23%)

USD0.19B

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -59.58% 33% F 28% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -59.58% 33% F 28% F
Trailing 12 Months  
Capital Gain -62.29% 35% F 28% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -62.29% 35% F 27% F
Trailing 5 Years  
Capital Gain 197.00% 77% C+ 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 197.00% 77% C+ 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 59.28% 88% B+ 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 59.28% 88% B+ 93% A
Risk Return Profile  
Volatility (Standard Deviation) 134.46% 16% F 8% F
Risk Adjusted Return 44.09% 60% D- 81% B-
Market Capitalization 1.33B 72% C- 79% C+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 20.71 74% C 44% F
Price/Book Ratio 2.53 59% F 34% F
Price / Cash Flow Ratio 18.91 28% F 14% F
EV/EBITDA 16.65 34% F 14% F
Management Effectiveness  
Return on Equity 5.67% 75% C 65% D
Return on Invested Capital 11.52% 83% B 79% C+
Return on Assets 6.66% 93% A 88% B+
Debt to Equity Ratio 40.24% 56% F 43% F
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 13.51 14% F 6% F
Short Percent 17.62% 8% F 8% F
Beta 0.64 78% C+ 76% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.